3D Bioprinting Market

Global 3D Bioprinting Market: Global Size, Trends, Competitive, Historical & Forecast Analysis, 2022-2028: Increasing demand for 3D bioprinting in pharmaceuticals industry and growing prevalence of cardiovascular diseases are some of the major factors driving the growth of the Global 3D Bioprinting Market.

The 3D Bioprinting Market is valued at USD 1.84 Billion in 2021 and is expected to reach USD 6.21 Billion by 2028 with a CAGR of 18.96% over the forecast period.

Scope-

Three-dimensional (3D) bioprinting refers to the use of 3D printing-like techniques to assemble biomaterials to produce cells, growth factors, and/or biomedical parts, often with the intent of mimicking natural tissue characteristics. Typically, 3D bioprinting uses a layer-by-layer method to deposit materials known as bio-inks to create tissue-like structures that are used in various medical and tissue engineering fields. 3D bioprinting encompasses a wide range of bioprinting techniques and biomaterials. Bioprinting can be used to print models of tissues and organs to help research drugs and potential treatments. However, translating printed living cellular constructs into clinical applications faces many challenges due to the complexity and cell numbers required to create functional organs.

The outbreak of COVID-19 has positively impacted the 3D bioprinting industry. The pandemic has changed the lives of people around the world, with the number of cases increasing rapidly. The pandemic has resulted in an increase in the number of coronavirus patients worldwide and strained the health care sector with limited hospital staff. Therefore, in response to the increasing cases of coronavirus, many 3D bioprinting companies are responding to the crisis by offering their expertise to reduce the burden on supply chains and governments. Due to the ever-increasing cases of COVID-19, the demand for 3D bioprinters is increasing in the market.

The global 3D bioprinting market is segmented on the technology, application, end-user, region & country level. Based on technology, the global 3D bioprinting market is segmented into multi-phase jet solidification, stereolithography (SLA), selective laser sintering, laminated object manufacturing (LOM), electron beam melting, fused deposition modeling (FDM), inkjet printing. By application, the global 3D bioprinting market is segmented into medical sensors, surgical simulation & training models, prosthetic devices, orthopedic implants, tissue engineering & regenerative medicine, dental implants, and others. By end-user, the global 3D bioprinting market is segmented into contract research organizations, medical device manufacturers, research & academic institutions, and pharmaceutical companies.

The regions covered in the global 3D bioprinting market report are North America, Europe, Asia-Pacific, Latin America, and the rest of the World. Based on country level, the market of global 3D bioprinting is sub divided into U.S., Mexico, Canada, U.K., France, Germany, China, Italy, India, Japan, Southeast Asia, Middle East Asia (Saudi Arabia, UAE, Egypt) GCC, Africa, etc.

Key Players-

Some major key players for the global 3D bioprinting market report cover prominent players like -

• 3D Bioprinting Solutions
• Electro Optical Systems
• Foldink Life Science Technologies
• Advanced Solutions Life Sciences LLC
• Aspect Biosystems Ltd.
• Allevi Inc.
• Bico group ab
• Bio3D Technologies Pte. Ltd.
• Collplant Biotechnologies Ltd.
• Cellink Global
• Cyfuse Biomedical K.K.
• EnvisionTEC Inc.
• Formlabs Inc.
• GE Healthcare
• Allevi Inc.
• Organovo Holdings Inc.
• VIVAX BIO LLC.
• Poietis
• GeSiM

Market Segmentation-

By Technology:

• Multi-phase Jet Solidification
• Stereolithography (SLA)
• Selective Laser Sintering
• Laminated Object Manufacturing (LOM)
• Electron Beam Melting
• Fused Deposition Modeling (FDM)
• Inkjet Printing

By Application:

• Medical Sensors
• Surgical Simulation & Training Models
• Prosthetic Devices
• Orthopedic Implants
• Tissue Engineering & Regenerative Medicine
• Dental Implants
• Others

By End-User:

• Contract Research Organizations
• Medical Device Manufacturers
• Research & Academic Institutions
• pharmaceutical Companies

By Regional & Country Level:

• North America

• U.S.
• Canada

• Europe

• U.K.
• France
• Germany
• Italy

• Asia Pacific

• China
• Japan
• India
• Southeast Asia

• Latin America

• Brazil
• Mexico

• Middle East and Africa

• GCC
• Africa
• Rest of Middle East and Africa 

Increasing Demand for 3D Bioprinting in Pharmaceuticals Industry, Rising Funding to Support 3D Bioprinting Research Activities, and Growing Prevalence of Cardiovascular Diseases Are Some of The Major Factors Driving the Growth of The Global 3D Bioprinting Market

One of the major factors in the growth of the 3D bioprinting market is the increasing demand for 3D bioprinting in the pharmaceutical industry. The growing demand for 3D bioprinting has led to the development of new technologies and processes that make creating 3D objects easier and faster. As technology opens new opportunities for the development of new medical treatments, the growth of the 3D bioprinting market is driven by the growing demand for personalised medicine as well as the growing need for customised structures and treatments. With each passing year, the technology is also becoming more affordable and accessible, making it an attractive option for clinical applications. For instance, as per the news published, on June 22^nd, 2022, Brinter launched the world's first multi-material, multi-fluidic 3D bioprinting tool. The device is defined by its broad material capabilities and hopes to enable high-precision tissue engineering and regenerative medicine applications, including tissue damage repair, biological function modification, and local disease treatment. This increase in demand will continue to accelerate in the future as technology continues to advance. Therefore, many innovations in 3D bioprinting promote the growth of the 3D bioprinting market.

In addition, the rising funding to support 3D bioprinting research activities is boosting the growth of the 3D bioprinting market. For instance, as per the news published on June 10^th, 2021, Finland-based 3D bioprinting start-up Brinter has revealed that it has received an investment worth €1.2 million. Furthermore, as per the news published on January 10^th, 2020, Canadian 3D bioprinting technology company Aspect Biosystems announced a $20 million (USD) Series A financing round to advance technology for 3D bioprinting human tissue. 3D bioprinting has rising applications in healthcare, attracting funding from government and private organizations. The fund provides financial and technical support at various development stages of 3D bioprinting techniques. Therefore, increasing the availability of funding will boost the 3D bioprinting market.

However, the high cost associated with 3D bioprinting may hinder the growth of the global 3D bioprinting market. Despite that, increasing demand for organ transplants may create more opportunities in the global 3D bioprinting market.

Asia Pacific Holds a Major Share in the Global 3D Bioprinting Market:

Geographically, Asia Pacific is holding a major share in the global 3D bioprinting market due to the increasing geriatric population, and other growing investment of government in research & development these factors boost the market. For instance, according to ageing Asia, as of 2019, around 139 (67.6 million males and 71.5 million females) million people living in India are above the age of 60 which is more than 10% of the country's total population. The proportion of elderly people is expected to nearly double to 19.5% in 2050, with 319 million people over the age of 60. Therefore, the increasing prevalence of the geriatric population and the number of diseases in old age is increasing greatly is expected to fuel the 3D bioprinting market growth over the forecast period.

North America is the fastest-growing region in the global 3D bioprinting market within the forecast period due to the increasing prevalence of chronic kidney disease (CKD), rising incorporation of IT in the healthcare industry, and growing demand for 3D bioprinting these factors boost the market. The increasing prevalence of chronic kidney disease is driving the growth of the market. For instance, according to the Centres for Disease Control and Prevention, on July 12^th, 2022; more than 1 in 7, that is 15% of United States adults or 37 million people, are estimated to have CKD. Therefore, the increasing prevalence of chronic kidney disease is expected to fuel the 3D bioprinting market growth over the forecast period.

Recent Developments-

CELLINK Established the Centre of Excellence in India with a Focus on 3D Bioprinting

On August 19^th, 2022; CELLINK, a global leader in developing 3D bioprinters, and the Indian Institute of Science (IISc) have announced a partnership to establish a Center of Excellence (CoE) for 3D bioprinting in Bangalore, India. The CoE, the first of its kind in the field, is housed at the Center for Biosystems Science and Engineering (BSSE) at IISc. The Center of Excellence will provide access to 3D bioprinting systems, allowing researchers to accelerate their work in critical applications with the goal of improving health outcomes.

Brinter Launched World's First Multi-Material, Multi-Fluidic 3D Bioprinting Tool

On June 22^nd, 2022; A Finland-based bioprinting firm, Brinter, launched what it claims is the world's first multi-material, multi-fluidic bioprinting printhead. Designed for use with the firm's own 3D bioprinters, the digital multifluidic printing tool head is currently in pilot testing with limited customers. Aimed at research institutions and pharmaceutical companies, the device is defined by its broad material capabilities and hopes to enable high-precision tissue engineering and regenerative medicine applications, including tissue damage repair, biological function modification, and local disease treatment.

CELLINK Launched the BIO MDX Series Designed for high-throughput Biofabrication and Precise 3D Bioprinting

On March 22^nd, 2021; CELLINK, the world's leading bioconversion company, launched the BIO MDX™ series, the next generation of bioprinters designed for high-throughput bio-fabrication and precision 3D bioprinting for biomedical manufacturing, including biocompatible medical devices. Over the past 5 years, 3D bioprinting has become the method of choice for researchers in tissue engineering, cell culturing, and regenerative medicine, creating a greater need for improved automation, precision, and reproducibility in bio-fabrication methods.

Report Analysis	Details
Historical data	2015 - 2020
Forecast Period	2021 - 2027
Market Size in 2021:	USD 1.84 Billion
Base year considered	2017
Forecast Period CAGR %:	18.96%
Market Size Expected in 2028:	USD 6.21 Billion
Tables, Charts & Figures:	175
Pages	200
Key Players/Companies	3D Bioprinting Solutions, Electro Optical Systems, Foldink Life Science Technologies, Advanced Solutions Life Sciences, LLC, Aspect Biosystems Ltd., Allevi Inc., Bico group ab, Bio3D Technologies Pte. Ltd., Collplant Biotechnologies Ltd., Cellink Global, Cyfuse Biomedical K.K., EnvisionTEC, Inc., Formlabs, Inc., GE Healthcare,  Allevi Inc., Organovo Holdings, Inc., VIVAX BIO, LLC., Poietis, GeSiM, and others.
Segments Covered	By Technology, By End-User, By Application
Regional Analysis	North America, U.S., Canada, , Europe, Germany, France, U.K., Italy, Spain, Sweden, Netherland, Turkey, Switzerland, Belgium, Rest of Europe, Asia-Pacific, South Korea, Japan, China, India, Australia, Philippines, Singapore, Malaysia, Thailand, Indonesia, Rest Of APAC, Latin America, Mexico, Colombia, Brazil, Argentina, Peru, Rest of South America, Middle East and Africa, Saudi Arabia, UAE, Egypt, South Africa, Rest Of MEA

Key Benefits-

• Global 3D Bioprinting Market report covers in-depth historical and forecast analysis
• Global 3D Bioprinting Market research report provides detail information about Market Introduction, Market Summary, Global market Revenue (Revenue USD), Market Drivers, Market Restraints, Market Opportunities, Competitive Analysis, Regional and Country Level.
• Global 3D Bioprinting Market report helps to identify opportunities in marketplace.
• Global 3D Bioprinting Market report covers extensive analysis of emerging trends and competitive landscape.